Tuli Health

Tuli Health built its platform specifically for independent pharmacies across the UK's 11,000-strong network, targeting these neighborhood retailers as distribution hubs for diagnostic testing. The company's founding assumption was sound: pharmacies already had customer trust, convenient locations, and existing infrastructure that could be repurposed for diagnostics. When they launched in June 2020, COVID-19 testing demand validated this positioning immediately. Pharmacies became natural access points for customers seeking nearby testing without long waits or travel. The early signal that confirmed their targeting was correct came from the urgent market need—people actively sought accessible testing options during the pandemic. However, the available information doesn't specify whether Tuli Health encountered resistance from certain pharmacy segments, how many pharmacies actually adopted the platform, or whether they discovered unexpected customer segments beyond their initial pharmacy-focused model. The case demonstrates that identifying the right intermediary (pharmacies) rather than selling directly to consumers proved strategically sound, though details about their customer acquisition challenges or pivots remain limited.

Tuli Health launched in June 2020 during peak COVID-19 anxiety, when testing bottlenecks created genuine customer frustration. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Rather than relying on surveys, they measured demand through actual pharmacy adoption rates—within weeks, independent pharmacies began requesting their software without prompting, recognizing immediate revenue opportunities. The real validation came through transaction data: customers consistently paid for tests at neighborhood pharmacies rather than traveling to centralized testing centers, proving convenience commanded real purchasing behavior. Early traction showed pharmacies reordering test supplies within days of initial stock, indicating genuine customer demand rather than one-time curiosity. The strongest signal emerged from word-of-mouth adoption across pharmacy networks—independent operators began recommending Tuli's platform to peers after seeing customer queues and repeat business. This peer-to-peer validation across 11,000 potential pharmacy partners demonstrated the model solved a tangible problem pharmacists faced: underutilized locations with idle staff. Revenue growth and inventory turnover rates provided concrete proof that demand extended beyond stated interest into sustained purchasing behavior.